<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05006859</url>
  </required_header>
  <id_info>
    <org_study_id>GHIV0321</org_study_id>
    <nct_id>NCT05006859</nct_id>
  </id_info>
  <brief_title>Wheelchair Positioning and Neuromuscular Diseases</brief_title>
  <acronym>BDD-POSIT-MNM</acronym>
  <official_title>Wheelchair Positioning and Neuromuscular Diseases Database (Retrospective and Prospective)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupement Hospitalier Intercommunal du Vexin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association Française contre les Myopathies (AFM), Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupement Hospitalier Intercommunal du Vexin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This database will describe sitting postural control in wheelchair, as well as PW pain, and&#xD;
      pressure ulcers associated with sitting, in patients with neuromuscular disease (NMD).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuromuscular diseases are genetic diseases of the muscle or its innervation (nerve&#xD;
      connection) causing respiratory, cardiac and especially motor difficulties which may require&#xD;
      use of wheelchair. However there is no standardized positioning protocol, so it seems&#xD;
      interesting to us to study wheelchair positioning in neuromuscular diseases).&#xD;
&#xD;
      The purpose of this study is to describe sitting posture in the wheelchair in patients with&#xD;
      neuromuscular disease, pain associated with using the wheelchair, but also to assess the&#xD;
      effectiveness of the recommended equipment making the same evaluations in follow-up&#xD;
      consultation (a few months after receipt of the prescribed TAP).&#xD;
&#xD;
      Posture is assessed by the tool: Measurement of Postural Control in Seated Postural Control&#xD;
      Measure for Adults 2.0 (SPCMA 2.0), which is a validated tool.&#xD;
&#xD;
      Pain is assessed by a Simple Verbal Scale or by a Visual Analog Scale. This database could&#xD;
      allow providing guidelines of good practice, for wheelchair positioning for patients with&#xD;
      neuromuscular disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of postural wheelchair disorders in the neuromuscular disease population</measure>
    <time_frame>At the beginning and the end of the study, an average of 6 months</time_frame>
    <description>Measurement of Posture by the tool: Measurement of Postural Control in Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0) score (0 = normal, 1 = mild, 2 = moderated and 3 = severe)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of pain associated with using the wheelchair</measure>
    <time_frame>At the beginning and the end of the study (before positioning equipment and few months after use), an average of 6 months</time_frame>
    <description>Assessment of initial pain (before positioning equipment) and pain after positioning equipment.&#xD;
Pain is assessed by a Simple Verbal Scale or by a Visual Analog Scale (0 to 10) (0 = no pain and 10 is the strongest pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the incidence of pressure ulcers associated with sitting in NMD</measure>
    <time_frame>At the beginning and the end of the study (before positioning equipment and few months after use), an average of 6 months</time_frame>
    <description>Observation of the topography and the stage of ulcers associated with sitting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the proportion of technical postural aids prescribed for patients who accept the positioning equipment</measure>
    <time_frame>At the end of the study, an average of 6 months</time_frame>
    <description>Counts of the numbers of technical postural aids prescribed during consultation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the technical postural aids efficacy</measure>
    <time_frame>At the beginning and the end of the study (before positioning equipment and few months after use), an average of 6 months</time_frame>
    <description>Comparison of Postural Control in Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0) score before and after using of technical postural aids (0 = normal, 1 = mild, 2 = moderated and 3 = severe)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Neuromuscular Diseases</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cohorte</intervention_name>
    <description>Assessment of postural wheelchair disorders, as well as PW pain, and pressure ulcers associated with sitting</description>
    <other_name>Questionnaire</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with neuromuscular disease, using Wheelchair, seen in positioning consultation by&#xD;
        N. Pellegrini and / or E. Dupitier&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria :&#xD;
&#xD;
          -  Patient with neuromuscular disease&#xD;
&#xD;
          -  Written informed consent (IC) obtained&#xD;
&#xD;
          -  Adult patients (&gt; 18 years) Or&#xD;
&#xD;
          -  Adults under guardianship who has given theirs oral consent and guardian's consent&#xD;
             obtained Or&#xD;
&#xD;
          -  Childs who has given theirs oral consent and parents' consent obtained&#xD;
&#xD;
          -  Wheelchair user&#xD;
&#xD;
        Exclusion Criteria :&#xD;
&#xD;
        • Patient not seen in positioning consultation by N. Pellegrini and / or E. Dupitierr&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Nadine Pellegrini</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupement Hospitalier Intercommunal du Vexin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maryline Delattre</last_name>
    <phone>+331.30.75.41.31</phone>
    <email>maryline.delattre@ght-novo.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Audrey Gilibert</last_name>
    <phone>+331.30.75.40.40</phone>
    <phone_ext>72.57</phone_ext>
    <email>audrey.gilibert@ght-novo.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Groupement Hospitalier Intercommunal du Vexin / Site d'Aincourt - Pôle Soins de Suite et de Réadaptation spécialisés</name>
      <address>
        <city>Aincourt</city>
        <zip>95510</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadine Pellegrini, Dr</last_name>
      <phone>+33 1 34 79 44 75</phone>
      <email>nadine.pellegrini@ght-novo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique du Positionnement de l'AFM</name>
      <address>
        <city>Évry</city>
        <zip>91 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elise Dupitier</last_name>
      <phone>+33 1 69 47 28 28</phone>
      <email>edupitier@afm-telethon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 11, 2021</study_first_submitted>
  <study_first_submitted_qc>August 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuromuscular disease</keyword>
  <keyword>Postural wheelchair disorders</keyword>
  <keyword>Wheelchair positioning</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

